
Hannah Kuchler
Global Pharmaceuticals Correspondent at Financial Times
Global pharma editor @FT, leading science and pharma team. Emmy-nominated, Loeb winner. Previously NY, SF, HK. On parental leave, email [email protected].
Articles
-
2 days ago |
ft.com | Hannah Kuchler |Mercedes Ruehl
Roche has said it will spend $50bn on manufacturing and research and development in the US, becoming the latest pharmaceutical company to...
-
2 days ago |
ft.com | Hannah Kuchler
Millions of Americans must decide whether to give up on new weight-loss drugs or move to more expensive branded versions, after the US...
-
3 days ago |
ft.com | Hannah Kuchler |John Reed
The generic drug industry has warned that US tariffs on pharmaceuticals risk causing shortages of medicines including cancer treatments,...
-
3 days ago |
ft.com | Sarah Neville |Hannah Kuchler |Clive Cookson
Gavi, the international vaccine alliance, is trying to convince President Donald Trump’s administration to maintain vital funding for the...
-
5 days ago |
ft.com | Jude Webber |Hannah Kuchler
The peak of Croagh Patrick dominates the skyline of Westport, a pretty town on Ireland’s Atlantic coast.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 19K
- Tweets
- 2K
- DMs Open
- Yes

RT @AnnaSophieGross: NEW: AstraZeneca has ditched plans to build new vaccine manufacturing plant in Merseyside, less than a year after it w…

Scoop: AstraZeneca ditches plans to invest in a vaccine manufacturing plant in Speke. With @AnnaSophieGross https://t.co/kg8kvJlzkV

RT @ClaerB: There are high hopes for #bonusseason in the City this year - but how does yours measure up? Early entries to the FT's Bonus Su…